Investment in procedural medical devices is safer for valuation, says E Squared's Les Funtleyder Previous Biotech is going to have a hard time until the end of rate cycle, says E Squared's Les Funtleyder Next Everybody will sell first and ask questions later with PBM stocks: E Squared's Les Funtleyder
Investment in procedural medical devices is safer for valuation, says E Squared's Les Funtleyder Previous Biotech is going to have a hard time until the end of rate cycle, says E Squared's Les Funtleyder Next Everybody will sell first and ask questions later with PBM stocks: E Squared's Les Funtleyder
